• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Ann H. Partridge, MD, MPH


  • Bunnell CA, Gross AH, Weingart SN, Kalfin MJ, Partridge A, Lane S, Burstein HJ, Fine B, Hilton NA, Sullivan C, Hagemeister EE, Kelly AE, Colicchio L, Szabatura AH, Winer EP, Salisbury M, Mann S.High performance teamwork training and systems redesign in outpatient oncology.BMJ Qual Saf. 2013 May;22(5):405-13.
  • Ruddy KJ, Meyer ME, Giobbie-Hurder A, Emmons KM, Weeks JC, Winer EP, Partridge AH.Long-Term Risk Perceptions of Women With Ductal Carcinoma In Situ.Oncologist. 2013 Apr 8.
  • Ruddy KJ, Giobbie-Hurder A, Giordano SH, Goldfarb S, Kereakoglow S, Winer EP, Partridge AH.Quality of life and symptoms in male breast cancer survivors.Breast. 2013 Apr;22(2):197-9.
  • Partridge AH, Ruddy KJ, Kennedy J, Winer EP.Model program to improve care for a unique cancer population: young women with breast cancer.J Oncol Pract. 2012 Sep;8(5):e105-10.
  • Roth BJ, Krilov L, Adams S, Aghajanian CA, Bach P, Braiteh F, Brose MS, Ellis LM, Erba H, George DJ, Gilbert MR, Jacobson JO, Larsen EC, Lichtman SM, Partridge AH, Patel JD, Quinn DI, Robison LL, von Roenn JH, Samlowski W, Schwartz GK, Vogelzang NJ.Clinical cancer advances 2012: annual report on progress against cancer from the american society of clinical oncology.J Clin Oncol. 2013 Jan 1;31(1):131-61.
  • Partridge AH, Norris VW, Blinder VS, Cutter BA, Halpern MT, Malin J, Neuss MN, Wolff AC, .Implementing a breast cancer registry and treatment plan/summary program in clinical practice: a pilot program.Cancer. 2013 Jan 1;119(1):158-63.
  • Blinder VS, Norris VW, Peacock NW, Griggs JJ, Harrington DP, Moore A, Theriault RL, Partridge AH, .Patient perspectives on breast cancer treatment plan and summary documents in community oncology care: a pilot program.Cancer. 2013 Jan 1;119(1):164-72.
  • Toi M, Benson JR, Winer EP, Forbes JF, von Minckwitz G, Golshan M, Robertson JF, Sasano H, Cole BF, Chow LW, Pegram MD, Han W, Huang CS, Ikeda T, Kanao S, Lee ES, Noguchi S, Ohno S, Partridge AH, Rouzier R, Tozaki M, Sugie T, Yamauchi A, Inamoto T.Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference.Breast Cancer Res Treat. 2012 Nov 11.
  • Rosenberg SM, Tamimi RM, Gelber S, Ruddy KJ, Kereakoglow S, Borges VF, Come SE, Schapira L, Winer EP, Partridge AH.Body image in recently diagnosed young women with early breast cancer.Psycho Oncology. 2012 Nov 7.
  • Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Partridge AH.Time to diagnosis and breast cancer stage by race/ethnicity.Breast Cancer Res Treat. 2012 Oct 26.
  • Ruddy KJ, Partridge AH.Fertility (male and female) and Menopause.J Clin Oncol. 2012 Oct 20;30(30):3705-11.
  • Freedman RA, Virgo KS, Labadie J, He Y, Partridge AH, Keating NL.Receipt of locoregional therapy among young women with breast cancer.Breast Cancer Res Treat. 2012 Oct;135(3):893-906.
  • Sepucha KR, Belkora JK, Chang Y, Cosenza C, Levin CA, Moy B, Partridge A, Lee CN.Measuring decision quality: psychometric evaluation of a new instrument for breast cancer surgery.BMC Med Inform Decis Mak. 2012;12:51.
  • Bober SL, Giobbie-Hurder A, Emmons KM, Winer E, Partridge A.Psychosexual Functioning and Body Image Following a Diagnosis of Ductal Carcinoma In Situ.The Journal Of Sexual Medicine. 2012 Jul 19.
  • Partridge AH, Hughes ME, Ottesen RA, Wong YN, Edge SB, Theriault RL, Blayney DW, Niland JC, Winer EP, Weeks JC, Tamimi RM.The effect of age on delay in diagnosis and stage of breast cancer.Oncologist. 2012;17(6):775-82.
  • Ruddy KJ, Gelber S, Ginsburg ES, Schapira L, Abusief ME, Meyer ME, Partridge AH.Menopausal symptoms and fertility concerns in premenopausal breast cancer survivors: a comparison to age- and gravidity-matched controls.Menopause. 2011 Jan;18(1):105-8.
  • Lee CN, Belkora J, Chang Y, Moy B, Partridge A, Sepucha K.Are patients making high-quality decisions about breast reconstruction after mastectomy? [outcomes article].Plast Reconstr Surg. 2011 Jan;127(1):18-26.
  • Joffe H, Partridge A, Giobbie-Hurder A, Li X, Habin K, Goss P, Winer E, Garber J.Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.Menopause.;17(5):908-16.
  • Partridge AH,Ruddy KJ,Gelber S,Schapira L,Abusief M,Meyer M,Ginsburg E.Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.Fertil Steril. 2010 Jul;94(2):638-44.
  • Peppercorn J, Shapira I, Collyar D, Deshields T, Lin N, Krop I, Grunwald H, Friedman P, Partridge AH, Schilsky RL, Bertagnolli MM.Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology.J Clin Oncol. 2010 May 20;28(15):2635-40.
  • Partridge AH, Archer L, Kornblith AB, Gralow J, Grenier D, Perez E, Wolff AC, Wang X, Kastrissios H, Berry D, Hudis C, Winer E, Muss H.Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104.J Clin Oncol. 2010 May 10;28(14):2418-22.
  • de Moor JS, Partridge AH, Winer EP, Ligibel J, Emmons KM.The role of socioeconomic status in adjustment after ductal carcinoma in situ.Cancer. 2010 Mar 1;116(5):1218-25.
  • Abusief ME, Missmer SA, Ginsburg ES, Weeks JC, Partridge AH.The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer.Cancer. 2010 Feb 15;116(4):791-8.
  • Partridge AH, Winer EP.On mammography--more agreement than disagreement.N Engl J Med. 2009 Dec 24;361(26):2499-501.
  • Sepucha KR,Ozanne EM,Partridge AH,Moy B.Is There a Role for Decision Aids in Advanced Breast Cancer?.Med Decis Making.;29(4):475-82.
  • Ruddy KJ, Partridge AH.Breast cancer in young women: clinical decision-making in the face of uncertainty.Oncology (Huntingt). 2009 May;23(6):474, 477.
  • Ozanne EM, Partridge A, Moy B, Ellis KJ, Sepucha KR.Doctor-patient communication about advance directives in metastatic breast cancer.J Palliat Med. 2009 Jun;12(6):547-53.
  • Muss HB,Berry DA,Cirrincione CT,Theodoulou M,Mauer AM,Kornblith AB,Partridge AH,Dressler LG,Cohen HJ,Becker HP,Kartcheske PA,Wheeler JD,Perez EA,Wolff AC,Gralow JR,Burstein HJ,Mahmood AA,Magrinat G,Parker BA,Hart RD,Grenier D,Norton L,Hudis CA,Winer EP.Adjuvant chemotherapy in older women with early-stage breast cancer.N Engl J Med. 2009 May 14;360(20):2055-65.
  • Partridge AH,Winer EP.Sharing study results with trial participants: time for action.J Clin Oncol. 2009 Feb 20;27(6):838-9.
  • Ligibel JA,Partridge A,Giobbie-Hurder A,Golshan M,Emmons K,Winer EP.Physical activity behaviors in women with newly diagnosed ductal carcinoma-in-situ.Ann Surg Oncol. 2009 Jan;16(1):106-12.
  • Partridge A,Winer JP,Golshan M,Bellon JR,Blood E,Dees EC,Sampson E,Emmons KM,Winer E.Perceptions and management approaches of physicians who care for women with ductal carcinoma in situ.Clin Breast Cancer. 2008 Jun;8(3):275-80.
  • Peppercorn J,Partridge AH.Breast cancer in young women: a new color or a different shade of pink?.J Clin Oncol. 2008 Jul 10;26(20):3303-5.
  • Partridge AH,Wolff AC,Marcom PK,Kaufman PA,Zhang L,Gelman R,Moore C,Lake D,Fleming GF,Rugo HS,Atkins J,Sampson E,Collyar D,Winer EP.The impact of sharing results of a randomized breast cancer clinical trial with study participants.Breast Cancer Res Treat. 2009 May;115(1):123-9.
  • Partridge AH.Fertility preservation: a vital survivorship issue for young women with breast cancer.J Clin Oncol. 2008 Jun 1;26(16):2612-3.
  • Ligibel JA, Campbell N, Partridge A, Chen WY, Salinardi T, Chen H, Adloff K, Keshaviah A, Winer EP.Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors.J Clin Oncol. 2008 Feb 20;26(6):907-12.
  • Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, Ligibel J, de Moor JS, Weeks J, Emmons K, Winer E.Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study.Journal of the National Cancer Institute. 2008 Feb 20;100(4):243-51.
  • Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A.Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer.J Clin Oncol. 2008 Feb 1;26(4):556-62.
  • Duffy C, Perez K, Partridge A.Implications of phytoestrogen intake for breast cancer.CA Cancer J Clin. 2007 Sep-Oct;57(5):260-77. Review.
  • Partridge AH, Ruddy KJ.Fertility and adjuvant treatment in young women with breast cancer.Breast. 2007 Dec;16 Suppl 2:S175-81. Review.
  • Partridge A, Gelber S, Gelber RD, Castiglione-Gertsch M, Goldhirsch A, Winer E.Age of menopause among women who remain premenopausal following treatment for early breast cancer: Long-term results from International Breast Cancer Study Group Trials V and VI.Eur J Cancer. 2007 Jul;43(11):1646-53.
  • Weingart SN, Flug J, Brouillard D, Morway L, Partridge A, Bartel S, Shulman LN, Connor M.Oral chemotherapy safety practices at US cancer centres: questionnaire survey.BMJ. 2007 Feb 24;334(7590):407.
  • Tolaney SM, Partridge AH, Sheib RG, Burstein HJ, Winer EP.Pneumocystis carinii pneumonia during dose-dense chemotherapy for breast cancer.J Clin Oncol. 2006 Nov 20;24(33):5330-1.
  • Leining MG, Gelber S, Rosenberg R, Przypyszny M, Winer EP, Partridge AH.Menopausal-type symptoms in young breast cancer survivors.Ann Oncol. 2006 Dec;17(12):1777-82.
  • Burstein HJ, Mayer E, Patridge AH, O'Kane H, Litsas G, Come SE, Hudis CA, Goldstein DF, Muss HB, Winter EP, Garber JE.Inadvertent use of aromatase inhibitors in patients with breast cancer with residual ovarian function: cases and lessons.Clin Breast Cancer. 2006 Jun;7(2):158-61.
  • , Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K.American Society of Clinical Oncology recommendations on fertility preservation in cancer patients.J Clin Oncol. 2006 Jun 20;24(18):2917-31.
  • Partridge AH.Non-adherence to endocrine therapy for breast cancer.Ann Oncol. 2006 Feb;17(2):183-4.
  • Burstein HJ, Parker LM, Keshaviah A, Doherty J, Partridge AH, Schapira L, Ryan PD, Younger J, Harris LN, Moy B, Come SE, Schumer ST, Bunnell CA, Haldoupis M, Gelman R, Winer EP.Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy.J Clin Oncol. 2005 Nov 20;23(33):8340-7.
  • Peppercorn J, Partridge A, Burstein HJ, Winer EP.Standards for follow-up care of patents with breast cancer.Breast. 2005 Dec;14(6):500-8.
  • Partridge AH.Young women's preferences about adjuvant endocrine therapy for breast cancer.Lancet Oncol. 2005 Aug;6(8):542-4.
  • Simon B, Lee SJ, Partridge AH, Runowicz CD.Preserving fertility after cancer.CA Cancer J Clin. 2005 Jul-Aug;55(4):211-28; quiz 263-4.
  • Partridge A, Schapira L.Pregnancy and breast cancer: epidemiology, treatment, and safety issues.Oncology (Huntingt). 2005 May;19(6):693-7; discussion 697-700.
  • Partridge AH, Winer EP.Fertility after breast cancer: questions abound.J Clin Oncol. 2005 Jul 1;23(19):4259-61.
  • Partridge AH, Wong JS, Knudsen K, Gelman R, Sampson E, Gadd M, Bishop KL, Harris JR, Winer EP.Offering participants results of a clinical trial: sharing results of a negative study.Lancet. 2005 Mar 12-18;365(9463):963-4.
  • Partridge AH, Hackett N, Blood E, Gelman R, Joffe S, Bauer-Wu S, Knudsen K, Emmons K, Collyar D, Schilsky RL, Winer EP.Oncology physician and nurse practices and attitudes regarding offering clinical trial results to study participants.J Natl Cancer Inst. 2004 Apr 21;96(8):629-32.
  • Partridge AH, Winer EP, Burstein HJ.Follow-up care of breast cancer survivors.Semin Oncol. 2003 Dec;30(6):817-25.
  • Nekhlyudov L, Partridge A.Breast cancer risk communication: challenges and future research directions: workshop report (United States).Cancer Causes Control. 2003 Apr;14(3):235-9.
  • Partridge AH, Burstein HJ, Gelman RS, Marcom PK, Winer EP.Do patients participating in clinical trials want to know study results?.J Natl Cancer Inst. 2003 Mar 19;95(6):491-2.
  • Partridge AH, Wang PS, Winer EP, Avorn J.Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.J Clin Oncol. 2003 Feb 15;21(4):602-6.
  • Partridge AH, Winer EP.Informing clinical trial participants about study results.JAMA. 2002 Jul 17;288(3):363-5.
  • Partridge AH, Avorn J, Wang PS, Winer EP.Adherence to therapy with oral antineoplastic agents.J Natl Cancer Inst. 2002 May 1;94(9):652-61.
  • Burstein HJ, Partridge AH, Lesnikoski BA.Treatment of breast cancer during pregnancy.Expert Opin Pharmacother. 2002 Apr;3(4):423-8.
  • Partridge AH, Bunnell CA, Winer EP.Quality of life issues among women undergoing high-dose chemotherapy for breast cancer.Harrison's Principles of Internal Medicine. 2001 Winter;14:41-50.
  • Burstein HJ, Kuter I, Campos SM, Gelman RS, Tribou L, Parker LM, Manola J, Younger J, Matulonis U, Bunnell CA, Partridge AH, Richardson PG, Clarke K, Shulman LN, Winer EP.Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer.J Clin Oncol. 2001 May 15;19(10):2722-30.